Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1476 to 1500 of 2422

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Dapagliflozin in combination therapy for treating type 2 diabetesTA288
Nivolumab for previously treated advanced renal cell carcinomaTA417
Dapagliflozin in triple therapy for treating type 2 diabetesTA418
Apremilast for treating moderate to severe plaque psoriasisTA419
Endoscopic transluminal pancreatic necrosectomyIPG567
Percutaneous insertion of craniocaudal expandable implants for vertebral compression fractureIPG568
Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy for treating morbid obesityIPG569
High-throughput non-invasive prenatal testing for fetal RHD genotypeDG25
Minimal change disease and focal segmental glomerulosclerosis in adults: rituximabES1
Physical health of people in prisonNG57
Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitorTA415
Elbasvir–grazoprevir for treating chronic hepatitis CTA413
Cobimetinib in combination with vemurafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanomaTA414
Psychosis and schizophrenia in children and young people: recognition and managementCG155
Needle-free arterial non-injectable connectorMIB85
Coeliac diseaseQS134
Single-incision short sling mesh insertion for stress urinary incontinence in womenIPG566
Children's attachmentQS133
Woundchek Protease Status for assessing elevated protease status in chronic woundsMIB83
Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancerTA411
Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastasesTA412
Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerTA406
Secukinumab for active ankylosing spondylitis after treatment with non-steroidal anti-inflammatory drugs or TNF-alpha inhibitorsTA407
Pegaspargase for treating acute lymphoblastic leukaemiaTA408
Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusionTA409

Results per page

  1. 10
  2. 25
  3. 50
  4. All